Nine Biopharm
PrivateLast Round
Series A
Dec 20, 2021
Total Funding Raised
$6.75M
Company Overview
Nine Biopharm operates in Healthcare & Life Sciences and is based in Suwon. Its latest recorded funding round was a Series A round in December 2021.
Nine Biopharm is a biomaterials company that develops peptide-based materials for pharmaceuticals, medical devices, and cosmetics using a proprietary computer simulation platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Fashion & Beauty, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nine Biopharm Comparables
Compare Nine Biopharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SupadElixir Co., Ltd. | 79% | |
| PharmaResearch | 76% | |
| Caregen Co., Ltd. | 75% |
For institutional investors. Book with your work email.
Nine Biopharm Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Nine Biopharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capstone Partners | Series A |
| Korea Asset Investment Securities | Series A |
| Laplace Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 20, 2021
$7M round led by Korea Asset Investment Securities.
For institutional investors. Book with your work email.
Nine Biopharm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nine Biopharm's valuation, stock price, and market status.
Is Nine Biopharm a public or private company?
Nine Biopharm is a private company.
What is the current stock price of Nine Biopharm?
Nine Biopharm is a private company, so its shares have no public market price. Caplight tracks Nine Biopharm's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nine Biopharm worth (valuation)?
Valuation information for Nine Biopharm is not publicly available.
Can I buy Nine Biopharm stock?
Nine Biopharm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nine Biopharm's last funding round?
Nine Biopharm's most recent funding round was Series A on December 20, 2021.
Who are the main investors in Nine Biopharm?
Key investors in Nine Biopharm include Capstone Partners, Korea Asset Investment Securities, Laplace Partners.
Will Nine Biopharm IPO soon?
No public IPO plans have been announced for Nine Biopharm.
How can I track Nine Biopharm secondary market activity?
Caplight tracks bids, offers, and trades in Nine Biopharm's shares on secondary markets.